{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:13:01Z","timestamp":1792174381316,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-05911"],"award-info":[{"award-number":["2019-05911"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013281","name":"Joint Programming Initiative on Antimicrobial Resistance","doi-asserted-by":"publisher","award":["2015-06825"],"award-info":[{"award-number":["2015-06825"]}],"id":[{"id":"10.13039\/100013281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013281","name":"Joint Programming Initiative on Antimicrobial Resistance","doi-asserted-by":"publisher","award":["2015-06286"],"award-info":[{"award-number":["2015-06286"]}],"id":[{"id":"10.13039\/100013281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cmi.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T11:35:39Z","timestamp":1585222539000},"page":"1214-1221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments"],"prefix":"10.1016","volume":"26","author":[{"given":"P.","family":"Wistrand-Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-P.","family":"Skarp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.I.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lagerb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"T\u00e4ngd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.03.007_bib1","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib3","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/jac\/dku168","article-title":"Combination therapy for carbapenem-resistant Gram-negative bacteria","volume":"69","author":"Paul","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2020.03.007_bib5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2016.09.014","article-title":"Synergistic combinations of polymyxins","volume":"48","author":"Lenhard","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.03.007_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mimet.2016.11.001","article-title":"Evaluation of automated time-lapse microscopy for assessment of in\u00a0vitro activity of antibiotics","volume":"132","author":"Ungphakorn","year":"2017","journal-title":"J\u00a0Microbiol Methods"},{"key":"10.1016\/j.cmi.2020.03.007_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmi.2017.10.029","article-title":"Automated time-lapse microscopy a novel method for screening of antibiotic combination effects against multidrug-resistant Gram-negative bacteria","volume":"24","author":"Ungphakorn","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.cmi.2020.03.007_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00857-17","article-title":"Colistin is extensively lost during standard in vitro experimental conditions","volume":"61","author":"Karvanen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib11","series-title":"Breakpoint tables for interpretation of MICs and zone diameters","year":"2019"},{"key":"10.1016\/j.cmi.2020.03.007_bib12","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dks261","article-title":"Identification of acquired antimicrobial resistance genes","volume":"67","author":"Zankari","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11908-017-0596-3","article-title":"Polymyxin resistance in Gram-negative pathogens","volume":"19","author":"Srinivas","year":"2017","journal-title":"Curr Infect Dis Rep"},{"issue":"11","key":"10.1016\/j.cmi.2020.03.007_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01423-17","article-title":"High-level resistance to colistin mediated by various mutations in the crrB gene among carbapenemase-producing Klebsiella pneumoniae","volume":"61","author":"Jayol","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib15","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JCM.00440-13","article-title":"Real-time optical antimicrobial susceptibility testing","volume":"51","author":"Fredborg","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2020.03.007_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cid\/civ964","article-title":"Updated US and European dose recommendations for intravenous colistin: how do they perform?","volume":"62","author":"Nation","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.03.007_bib17","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1128\/AAC.00009-16","article-title":"Amino acid substitutions of crrB responsible for resistance to colistin through crrC in Klebsiella pneumoniae","volume":"60","author":"Cheng","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib18","doi-asserted-by":"crossref","first-page":"a025387","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cmi.2020.03.007_bib19","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1073\/pnas.0711939105","article-title":"Rifamycin antibiotic resistance by ADP-ribosylation: structure and diversity of arr","volume":"105","author":"Baysarowich","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.cmi.2020.03.007_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00749-17","article-title":"Widespread fosfomycin resistance in Gram-negative bacteria attributable to the chromosomal fosA gene","volume":"8","author":"Ito","year":"2017","journal-title":"mBio"},{"issue":"7","key":"10.1016\/j.cmi.2020.03.007_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00073-17","article-title":"In vitro assessment of combined polymyxin B and minocycline therapy against Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae","volume":"61","author":"Huang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.cmi.2020.03.007_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02121-16","article-title":"Polymyxin B in combination with rifampin and meropenem against polymyxin B-resistant KPC-producing Klebsiella pneumoniae","volume":"61","author":"Diep","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib23","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jac\/dku065","article-title":"In\u00a0vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates","volume":"69","author":"Gaibani","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib24","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1128\/AAC.00741-13","article-title":"Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in\u00a0vitro time-kill experiments","volume":"58","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib25","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/jac\/dkw213","article-title":"Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in\u00a0vitro time-kill experiments","volume":"71","author":"Lagerb\u00e4ck","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib26","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1093\/jac\/dkx328","article-title":"Pharmacodynamics of fosfomycin against ESBL- and\/or carbapenemase-producing Enterobacteriaceae","volume":"72","author":"Fransen","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.cmi.2020.03.007_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01815-17","article-title":"Evaluation of activity and emergence of resistance of polymyxin B and ZTI-01 (fosfomycin for injection) against KPC-producing Klebsiella pneumoniae","volume":"62","author":"Diep","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijantimicag.2018.02.010","article-title":"Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model","volume":"52","author":"Bulman","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.03.007_bib29","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/AAC.01069-13","article-title":"Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin","volume":"57","author":"Clancy","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.03.007_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41467-018-02875-z","article-title":"Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics","volume":"9","author":"MacNair","year":"2018","journal-title":"Nat Commun"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2030149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2030149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:23:58Z","timestamp":1778592238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2030149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1198743X2030149X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.03.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}